Access & Regulatory
Navigate the Pathways That Connect Products to Patients.
Pricing, reimbursement, and regulatory strategy built on deep knowledge of African health authority dynamics and market access realities that no global template anticipates.
Market access in Africa is not a checklist. It is a relationship and a strategy — built over time, with people who understand both the science and the system.
Market access across African and Middle Eastern pharma markets is one of the most complex and underserved areas of commercial strategy. The diversity of pricing environments, reimbursement mechanisms, health authority expectations, and public procurement processes means that what constitutes a market access strategy in Morocco looks nothing like the approach required in Kenya, Nigeria, or Saudi Arabia.
Most global market access frameworks are built for European or US reimbursement dynamics. Applying them to African markets without modification consistently underdelivers — because the stakeholder landscape, the evidence requirements, and the negotiation dynamics are fundamentally different. Helix Bridge brings a genuine Africa-native perspective to market access: practitioners who have navigated these systems from the inside, over many years, across multiple markets.
On the regulatory side, the landscape is equally complex. African regulatory authorities are at very different stages of maturity and digitalisation, and the strategies for engaging them require both technical rigour and relationship management skills that can only be developed through direct experience. We support clients through registration strategy, dossier planning, authority engagement, and lifecycle maintenance — with the nuance that each market demands.
What We Deliver
- Market access strategy development: pricing strategy, reimbursement pathway mapping, and value dossier design adapted to specific African market contexts
- Health authority engagement strategy and stakeholder mapping across key MEA markets
- Public affairs strategy: advocacy planning, payer and government stakeholder engagement, and access barrier analysis
- Regulatory submission strategy: registration pathway selection, dossier planning, and timeline management across multiple African and Middle Eastern regulatory environments
- Regulatory intelligence: health authority capacity assessments, harmonisation landscape analysis (AMRH, ZAZIBONA, mSHRECO), and submission readiness reviews
- Pricing architecture for multi-country portfolios: reference pricing risk management, parallel import analysis, and differential pricing design
- Tender strategy and national procurement process support for both public sector and institutional markets
Who This Is For
Developing access strategies for products that need reimbursement, public procurement inclusion, or institutional adoption across African markets.
Planning multi-country registration programmes and needing a partner who understands the actual dynamics — not just the published guidelines — of African health authorities.
Operating in markets where access barriers are directly limiting revenue, and needing a strategy that addresses both the regulatory and commercial dimensions simultaneously.
Evaluating in-licensing opportunities or portfolio expansion decisions that depend on a realistic assessment of the access and regulatory pathway in target markets.
Access barriers are often the difference between a product that reaches patients and one that does not. Let's build the strategy that clears the path.
Discuss Your Access & Regulatory Needs →